Towards understanding the clinical significance of QT peak prolongation: a novel marker of myocardial ischemia independently demonstrated in two prospective studies by Wong, Kenneth Y-K. et al.
J Cardiol Curr Res 2015, 2(1): 00046Submit Manuscript | http://medcraveonline.com
Journal of Cardiology & Current Research
IntroductionPreventing cardiac deaths remains one of the greatest challenges in medicine in the 21st Century. There is evidence to suggest QT peak prolongation identi�ies patients who are at risk of death or non-fatal myocardial infarction (MI) [1]. The next step to reduce the risk of these patients would be to �ind out whether there are potentially treatable conditions associated with QT peak prolongation. A potential mechanism by which QT peak prolongation might predict death or non-fatal MI might be that QT peak prolongation is associated with myocardial ischaemia. In this paper, we will test the hypothesis that QT peak prolongation is associated with myocardial ischaemia. 
Methods
Study design
Patients: We aimed to test the hypothesis by studying two cohorts of patients to see how widely applicable this concept was. The �irst study included only stroke survivors in a University Teaching Hospital since there is evidence to suggest stroke 
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survivors with a long QT peak are at high risk of cardiac death [2]. The second study examined patients referred for exclusion of ischaemia and viability by stress echocardiography in a District General Hospital. The studies conformed to the principles outlined in the Declaration of Helsinki. Ethics approval was obtained from the respective institutional review committees (local research ethics committees). The study also had ARSAC approval (for nuclear myocardial perfusion scanning). Written consent was obtained from all patients. 
First study
Patients: We recruited 202 patients who made a good recovery and were at least one month after a recently documented CVA or TIA. The patients who had atrial �ibrillation or �lutter, bigeminy, paced rhythm or bundle branch block on their ECG were excluded for QT interval analysis. These ECG changes would make the QT interval dif�icult to measure reliably. Other exclusion criteria were as follows:
a. Over 90 years of age. 
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b. Patients who were living in nursing home or care of the elderly hospitals. 
Patients were also excluded from the study if they had 
moderate to severe asthma which contraindicated the use 
of dipyridamole without steroid cover. (Dipyridamole was the stressing agent for the nuclear stress scan). Moreover, 
patients with severe chronic obstructive pulmonary disease on 
theophylline medication were also excluded. 
ECG: Resting supine 12-lead ECGs (Marquette Medical 
Systems, USA) were recorded at 25mm/second.
QT peak measurements: QT peak was defined as the onset 
of QRS to the peak of the T wave in lead I. The T peak was defined 
as the point where the T wave had the maximum amplitude. This 
applied to inverted T waves too. If the T wave was biphasic, then 
the deflection with the higher amplitude was used. However, if the 
upward and the downward deflection were of equal amplitude, 
then the measurement would be omitted. QT peak was “heart 
rate corrected” using Bazett’s formula
1/2
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=
A single observer who was blinded to the nuclear myocardial 
perfusion study results digitized all the ECGs. 
Nuclear Stress myocardial perfusion study for 
myocardial ischaemia: The myocardial perfusion studies 
were carried out using dipyridamole as the stressing agent. 
All theophylline medications were withheld for 36 hours and 
caffeinated beverages for 12 hours before the study. The patient 
was attached to a cardiac monitor before administration of 
dipyridamole. Dipyridamole was slowly infused at 0.56mg/kg 
over about 4 minutes. This was followed by simple arm exercise 
for around 2 minutes. The patient was then injected with 400MBq 
of 99m-Technetium tetrofosmin. This gives a radiation dose of 
4 mSv /scan which is equivalent to 2 years natural background and is much less than the dose received from a study using 201-Thallium. 10 minutes after the injection of the radiopharmaceutical, the 
patient was given a small cup of water; a large cup of water was 
given 10 minutes prior to the start of imaging. This was to try to 
reduce the activity in the stomach and small bowel which might 
interfere with the reconstruction of the tomographic images. At 
45 minutes post injection a 180 degree tomographic acquisition 
was begun acquiring data from right anterior oblique to left 
posterior oblique using a dual head gamma camera fitted with 
high resolution collimators. The system was also fitted with a 
Beacon attenuation correction system. If the stress scan was 
abnormal, images obtained after an injection at rest, 
approximately 1 week later, were used to differentiate between infarction and ischaemia. 
The scans were assessed quantitatively. Each scan was scored 
out of 64, by dividing the left ventricle into 16 regions (4 apical, 3 
anterior, 3 lateral, 3 inferior, and 3 septal) and giving each region 
a score out of 4, indicating the degree of perfusion. The inducible 
ischaemia score was defined as the difference between the score 
obtained from the stress scan and that of the rest scan (i.e. Rest 
scan score-stress scan score). An inducible ischaemia score of 
greater than or equal to 12 was regarded as evidence of severe myocardial ischaemia. 
Second study
 166 consecutive consenting patients referred for stress 
echocardiography for exclusion of ischaemia/viability were recruited. 
Resting ECG: Resting 12-lead ECGs were again recorded at 
25mm/second, with the subject lying supine.
QT peak measurements: The definition of QT peak was as 
discussed above (same as First Study). QTpc was measured by 
a single observer (with ruler and callipers), again blinded to the 
clinical features of the patients as well as the outcome of the stress test. 
Echocardiography
In all cases, transthoracic echocardiography was undertaken using the GE Vingmed System Five (General Electric Company, 
USA). 
Stress Echocardiography 
Resting images were first recorded in four standard 
parasternal long axis, parasternal short axis, apical 4 chamber 
and apical 2 chamber views (PLX, PSX, AP4C and AP2C). Then 
IV Dobutamine infusion was started at 5 mcg/kg/min and the 
dose was increased every 3 minutes (to 10, 20, 30 and 40mcg/
kg/min). If the patient’s heart rate failed to increase adequately 
[i.e. to at least 85% maximum age predicted heart rate (220 
minus age)], then Atropine IV was administered at a dose of 
0.3 to 0.6 mg. All four views were recorded during the study at 
each stage (resting, low dose, intermediate and peak dose) after 
myocardial border enhancement with administration of 0.5 ml IV 
contrast agent [Sonovue® or Optison®] just prior to recording. 
The images were then analysed using the Echopac® software 
(General Electric Company, USA). 
In the stress echocardiography study, the cut-off for significant 
ischaemia was defined as a difference of 0.18 or more between 
the Wall Motion Score Index during stress compared with that 
at rest. This would be compatible with disease in all 3 coronary 
artery territories or significant disease in at least 1 territory. 
Statistical methods
SPSS was used for statistical analysis:In the Nuclear myocardial perfusion study on stroke survivors, Spearman Non-
parametric tests were used to test the relationship between 
QTpc and the inducible ischaemia score (rest score-stress score). 
UNIANOVA was used to assess if there was a significant 
difference in QT peak between patients who did and those who 
did not have myocardial ischaemia respectively, provided that the residuals were normally distributed (i.e. one-way 
Kolmogorov-Smirnov test 2-tailed p > 0.05). A p value of < 0.05 
was regarded as statistically significant. 
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ROC curves enabled us to determine sensitivity and specificity of different cut-off values of QT peak at diagnosing the presence of myocardial ischaemia. In the Stress Echocardiography 
study, UNIANOVA was employed where appropriate (i.e. if 
residuals of QT peak were normally distributed) to test the 
hypothesis generated by the study on stroke survivors. Again, 
ROC curves helped determine sensitivity and specificity of QT 
peak at diagnosing myocardial ischaemia. By cross-tabulating 
the presence of significant myocardial ischaemia with the cut-
off value of QTpc suggested by the first study, we were able to 
perform Chi-square and correlation testing. A Fisher’s Exact test 
2-tailed p < 0.05 would be regarded as statistically significant. 
Further, the Mantel-Haenszel common odds ratio was also 
computed to help us quantify the odds ratio estimate (with 95% 
confidence intervals). 
Results
Nuclear myocardial perfusion Study Results
Baseline characteristics of the patients are summarised in 
(Table 1). 
QTpc and myocardial ischaemia
QTpc correlated very weakly with inducible ischaemia on 
dipyridamole myocardial perfusion scan. (Spearman r=0.2, 
2-tailed p =0.041). [N=134]. Severe myocardial ischaemia 
(inducible ischaemia score 12 or more) was found in 4 patients. 
The mean QTpc of these patients with severe myocardial 
ischaemia was 354 (95% CI=331-377ms), compared with 325ms 
(95% CI 321-329ms) in those patients with lesser degrees of 
ischaemia or no ischaemia. (p=0.016). Figure 1 showed QTpc 
prolongation to 360ms or more had 92% specificity at diagnosing severe myocardial ischaemia. 
Reliability test 
Covariance matrix was used for analysis of reliability or intra 
observer reproducibility of QTpc measurements (N=12). Alpha 
was 0.97, indicating highly reproducible results. Further, inter-
observer reproducibility was tested in 17 cases, yielding an alpha 
of 0.94 (digitizing method).
Results of the stress echocardiography study
Patients: 166 patients were referred for stress 
echocardiography to exclude myocardial ischaemia/viability. 
14% had a history of MI. The patient characteristics are 
summarised in (Table 1).
Significant myocardial ischaemia demonstrated on 
stress echocardiography was associated with QT peak 
prolongation at rest
QTpc was measured in 102 patients with research-quality 
stress echocardiography. Of these, 13 had significant myocardial 
ischaemia. Significant myocardial ischaemia was associated 
with QT peak prolongation at rest (mean 354ms, 95% CI 341- 
367ms, compared with mean 332ms, 95% CI 327-337ms in 
those without significant ischaemia; p=0.002). [Figure 2] QT 
peak prolongation to 360ms or more was 88% specific at 
diagnosing significant myocardial ischaemia in the stress 
echocardiography study. [Figure 3] QT peak prolongation to 
360ms or more was associated with over 4-fold increase in the 
odds ratio of significant myocardial ischaemia. The Mantel-
Haenszel Common Odds Ratio Estimate=4.4, 95% CI=1.2-16.0, 
p=0.023.
Nuclear
Stress Scan
Cohort
Stress Echocardiography 
CohortAge 66 ± 9.4 57 ± 10.7
Sex, % female 40 52
Systolic blood pressure 
(BP), mmHg
144 ± 21.2 152 ± 24.5
Diastolic BP, mmHg 80 ± 11.0 89 ± 13.5Total cholesterol, mmol/L 4.9 ± 0.91 5.3 ± 1.29HDL cholesterol, mmol/L 1.3 ± 0.41 1.3 ± 0.55Glucose, mmol/L 6.2 ± 2.60 5.6 ± 1.14
% diabetic 12 11
Smoking habit, % current (or ex-smokers) 23 (51) 20 (34)QT peak (QTpc), ms 325 ± 23.2 337 ± 29.5
Table 1: Patient characteristics.
Data given are means ± SD
Figure 1: ROC curve demonstrating the sensitivities and specificities of different cut-off values of heart rate corrected QT peak (QTpc) at predicting severe myocardial ischaemia on nuclear scan in stroke survivors.
Cut-off value of QTpc I 
(ms) Sensitivity (%) Specificity (%)
320 100 45
350 75 85
360 50 92
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Discussion
We have shown the value of using QT peak prolongation as a 
marker of significant myocardial ischaemia in two independent 
cohorts of patients. This might explain why patients with QT peak prolongation are at higher risk of death or non-fatal MI [1]. 
Choice of cut-off value of abnormal QT peak
If QTpc was prolonged to 360ms or more in stroke survivors, 
the specificity at diagnosing severe myocardial ischaemia was 
92%. This cut-off value (360ms) was chosen to be validated 
in the second study. It can be argued that a lower cut-off value 
might be chosen to increase the sensitivity of the disease marker. 
For instance, 320ms had 100% sensitivity in both studies. 
Nevertheless, it should be noted that lesser degrees of ischaemia 
might be missed. QT peak prolongation to 360ms or above 
was associated with a several fold increase in the odds ratio of 
significant myocardial ischaemia in our stress echocardiography 
study. This finding may explain why QTpc of 360ms or above 
predicted cardiac death within 5 years of a stroke with a 
specificity of 76% [2].
Possible mechanism 
In 1999, Festa reported the relationship of heart rate 
corrected QT interval with subclinical atherosclerosis, as 
determined by carotid intima media thickness, in non-diabetic 
subjects in the Insulin Resistance Atherosclerosis Study [3]. 
Intima media thickness of the common carotid artery was 
measured by ultrasound and correlated significantly albeit 
weakly with QTc. This study raised the suspicion that the QT interval may serve as a marker for silent or subclinical i.e. 
clinically undetected atherosclerotic disease. More recently, an elegant study demonstrated how controlled (1 minute) 
occlusion of the left coronary artery led to QT prolongation. The 
authors observed the phenomenon that QT prolongation was 
inversely related to collateral function [4]. This might suggest a 
protective mechanism of human coronary collaterals against 
cardiac death. On the other hand, intriguingly, a small study of 
68 patients who underwent CABG had longer QT intervals and 
QT peak intervals (QT/RR slope) after revascularisation [5]. 
Why QT peak?
QT is traditionally defined as the interval between the start 
of the QRS complex and the end of the T wave. In measuring a 
QT interval, the beginning of the Q wave is usually identifiable. 
On the other hand, the end of the T wave is not always easily 
identifiable. This is because commonly, the T wave is flat. A flat T 
wave is seen normally in lead V1 as well as in certain 
pathological conditions such as myocardial ischaemia or 
hypokalaemia. If the patient’s potassium is less than 2.7, a U 
wave occurring after the T wave may exceed the T wave 
amplitude in the same lead [6]. The U wave adds to the difficulty 
in deciding where the T wave ends. This has led to a number of 
different definitions of T wave measurement, which inevitably 
causes a degree of confusion. Thus, the end of the T-wave has 
been variously defined as the point at the return of the T-wave 
to the isoelectric line, or at the nadir between the T- and the U-
waves, or at the intersection of an extrapolated line of the 
downward slope to the isoelectric line. The former two T-wave 
end definitions are most commonly used in practice. 
An attractive alternative way to obviate the confusion 
engendered by the difficulties in defining the end of the T wave is 
to measure the Q-T peak which is defined as the interval between 
the onset of the QRS complex and the peak of the T wave. Clearly, 
the start of the Q wave and the peak of the T wave are nearly 
always easily identifiable. Another reason why the use of QT peak 
measurements may be superior to the more commonly used QT 
end measurement is that some would argue that the onset of 
repolarisation is nearer to the T-wave peak [7]. There is some evidence to suggest that QT peak dispersion (maximum minus 
minimum QT peak), but not QT end dispersion, was longer in 
Figure 2: The relation between significant myocardial ischaemia and QT peak prolongation in the stress echocardiography study.
Figure 3: ROC Curve regarding sensitivities and specificities of 
different cut-off values of QTpc at diagnosing significant myocardial ischaemia in the stress echocardiography study.
Cut-off value of QTpc I
(ms) Sensitivity (%) Specificity (%)
320 100 34
350 54 78
360 39 88
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patients with myocardial ischaemia [8]. Measuring QT peak from 
all 12 leads of the ECG undoubtedly poses practical difficulties for 
the busy clinician. In the present paper, we have reported in two cohorts of patients that QT peak measured from a single lead of 
the ECG was associated with ischaemic heart disease. 
Clinical Implications
QT peak prolongation at rest identifies myocardial 
ischaemia, and may be used to risk-stratify patients for stress echocardiography or other non-invasive test for ischaemia. 
To expedite care of patients with suspected ischaemia who could not undergo treadmill testing for a variety of reasons e.g. 
walking with a stick, they should be triaged urgently for other 
non-invasive tests, especially if the patient has QTpc of 360ms 
or longer. If such non-invasive tests are not available in a timely 
fashion, coronary angiography should seriously be considered, 
as QTpc of 360ms or longer might indicate severe myocardial 
ischaemia in one territory or significant myocardial ischaemia in 
all 3 coronary artery territories. In the meantime, aspirin,  statin, 
and beta-blocker therapy should be considered as part of the 
overall cardiovascular risk assessment and anti-ischaemic therapy. 
Strengths and limitations of the present studyWe have examined the value of QT peak as a marker of 
myocardial ischaemia in two different cohorts of patients to test 
how widely applicable the hypothesis was. Whilst this could be 
regarded as strength of the study, we would like to emphasize 
the fact that the present study should not be regarded as a 
“derivation-validation” study in the strictest sense. There are 
significant differences in the two studies. The first study 
recruited only stroke survivors, many of whom did not have symptoms or past history of ischaemic heart disease. The 
second study investigated patients who were referred for stress 
echocardiography for exclusion of ischaemia/viability. Very few 
patients had severe myocardial ischaemia in the first 
hypothesis-generating study on stroke survivors whilst in the 
second study, 13% of the patients had significant myocardial 
ischaemia. The first study took place in a University Teaching 
Hospital and the second study was performed in a district 
general hospital. The first study used nuclear scans with 
dipyridamole as stressor to rule out ischaemia whilst the second 
study used dobutamine stress echocardiography. 
It can be argued that the use of 16 segment models might underestimate the degree of myocardial ischaemia from the true 
apex of the heart. i.e. 4 instead of 5 apical areas were interrogated. 
No anatomical data was obtained from cardiac catheterisation as part of the research studies. 
Future Research
Non-invasive coronary angiography using 320-row CT has 
now been shown to accurately diagnose significant coronary 
stenoses with near 100% sensitivity and > 90% specificity. These 
advanced scanners can now obtain all the necessary information 
in < 0.4 second, capturing up to 16cm of information, i.e. the whole heart, and therefore avoid over-scanning and over-ranging. This 
remarkable technological advance meant the radiation exposure 
of 320-row CT is now less than that of conventional cardiac 
catheterisation [9]. It would be of interest to see if QT peak 
prolongation might be associated with significant stenoses on CT coronary angiography. 
Conclusion
QT peak (QTpc) prolongation to 360ms or more should make 
us suspect the presence of significant myocardial ischaemia. Such 
patients merit further investigations for potentially treatable 
ischaemic heart disease to reduce their risk of subsequent death or non-fatal MI. 
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